Home › Calculator › ISCO Dividend Calculator 2026
ISCO Dividend DRIP Calculator 2026
1000.00% YieldHealthcareInternational Stem Cell Corporation · OTC
Price: $0.20 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ISCO pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ISCO snowball 📈
$10,000 in ISCO → $364921.29M in 10 years · $18,661,419,871.99/month
About International Stem Cell Corporation (ISCO) — Dividend Analysis 2026
International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings are products derived from its proprietary human parthenogenetic stem cells, a unique form of pluripotent stem cells. ISCO is actively engaged in developing specialized cell types, such as neural stem cells, which hold promise for treating Parkinson's disease and other disorders affecting the central nervous system. Beyond therapeutics, the company also develops, manufactures, and commercializes anti-aging skincare products and an extensive range of human cell culture products. Its diverse portfolio of human cell culture products serves as vital research tools across numerous scientific disciplines. This includes specialized cells and reagents designed for studying: Dermatology: Skin diseases, toxicology, and wound healing. Cardiovascular & Oncology: Heart and blood vessel conditions, and various cancers. Respiratory: Bronchial and tracheal conditions, toxicity, cystic fibrosis, asthma, and pathogenesis. Reproductive & Urological: Prostate, renal, bladder, corneal, and female reproductive system diseases, as well as general cellular physiology. Musculoskeletal & Metabolic: Skeletal muscle biology, diabetes, insulin pathways, muscle repair, and myotube development. The company also provides adult stem cells for regenerative medicine research and a full complement of reagents and supplements essential for cell growth, staining, and cryopreservation. Distribution of ISCO's skincare range occurs via its website and specialized professional channels, while its human cell culture products reach customers through a dedicated sales force, original equipment manufacturer (OEM) partners, and authorized brand distributors. Established in 2001, International Stem Cell Corporation maintains its headquarters in San Diego, California.
Compare ISCO with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ISCO DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ISCO position with:
🌍 ISCO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ISCO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1000.00% | 997.20% | $100,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 850.00% | 847.20% | $85,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 800.00% | 797.20% | $80,000 / yr |
| 🇬🇧 UK ISA | 0% | 1000.00% | 997.20% | $100,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 912.50% | 909.70% | $91,250 / yr |
| 🇨🇦 TFSA | 0% | 1000.00% | 997.20% | $100,000 / yr |
| 🇨🇦 CA Taxable | 25% | 750.00% | 747.20% | $75,000 / yr |
| 🇦🇺 Super (pension) | 15% | 850.00% | 847.20% | $85,000 / yr |
| 🇦🇺 AU Taxable | 30% | 700.00% | 697.20% | $70,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 736.25% | 733.45% | $73,625 / yr |
| 🇫🇷 FR Taxable | 30% | 700.00% | 697.20% | $70,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ISCO Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ISCO Dividend Payment Schedule
ISCO pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ISCO vs Healthcare Benchmarks
How ISCO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ISCO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ISCO Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-11 | 182,584 | $0.18 | $32.5K | ||
| A-Award | 2026-06-11 | 30,000 | $0.17 | $5.1K | ||
| A-Award | 2026-06-11 | 182,584 | $0.18 | $32.5K | ||
| A-Award | 2026-06-11 | 30,000 | $0.17 | $5.1K | ||
| A-Award | 2025-06-17 | 532,786 | $0.13 | $69.3K | ||
| A-Award | 2025-06-17 | 30,000 | $0.13 | $3.9K | ||
| A-Award | 2023-11-06 | 500,000 | $0.12 | $60.0K | ||
| A-Award | 2023-11-06 | 2,000,000 | $0.12 | $240.0K | ||
| A-Award | 2023-06-14 | 445,205 | $0.14 | $62.3K | ||
| A-Award | 2023-06-14 | 30,000 | $0.14 | $4.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where ISCO earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ISCO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
International Stem Cell Corporation (ISCO) is currently trading at $0.20, 78% below its 52-week high. The current dividend yield is 1000.00% based on an annual payout of $2.00 per share.
ISCO (International Stem Cell Corporation) — 1000.00% Dividend Yield Analysis
International Stem Cell Corporation (ISCO) is a healthcare stock currently trading at $0.20 with a dividend yield of 1000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (1000.00%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.